Long-term Follow-up of Subjects Treated with CAR T Cells

Launched by MASSACHUSETTS GENERAL HOSPITAL · Aug 23, 2021

Keywords

ClinConnect Summary

This clinical trial is focused on understanding the long-term effects of a treatment called CAR T cells, which is used for certain types of cancer. The goal is to check how safe this treatment is over a longer period and to see how well it continues to work for people after their initial treatment. The study is currently looking for participants who have already received CAR T cell therapy in earlier studies and are willing to provide their consent to take part in this follow-up.

To be eligible for the trial, participants should be aged 65 years or older and must have previously received CAR T cell treatment as part of the main study. If you join the study, you can expect to be monitored for any long-term side effects and to share your health updates with the research team. It's important to note that you would need to be able to follow the study's requirements to participate. This trial aims to gather valuable information that could help improve future cancer treatments.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Subjects will be asked to participate leading up to the last DF/HCC corresponding main study visit.
• Subjects meeting the following criteria are eligible for study participation:
• • Provision of voluntary written informed consent by subject
• • CAR T cells were administered in DF/HCC IRB corresponding main study
• Exclusion Criteria:
• Subjects meeting the following criterion are to be excluded from study participation:
• • - Subject unable to comply with study requirements